Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• Weighty Concerns: Tackling Obesity in Patients With Rheumatic Diseases
• Allopurinol Reduces Risk of Kidney Function Decline in Gout Patients
• HLA-B27 Linked to Earlier Disease Onset in White Patients With AS
• Machine Learning Effective for Detecting Flares in RA, Axial SpA
• Most Adults With Childhood-onset SLE Incur Significant Early Damage
• Past Rulings May Provide Insight on How Supreme Court Justice Kavanaugh May Impact Health Care
• Patients With AS Exhibit Lower Left Ventricular Myocardial Function
• Patients With RA Receptive to, Satisfied With IV Treatment
• Polymyalgia Rheumatica Increases GCA's Financial Burden 76% in First 3 Years
• Pre-visit Planning, Feedback Increase Pneumococcal Vaccination Rate in SLE
• Trump Administration Says It's Ending ACA 'Sabotage,' Experts Disagree
• Wearable Devices Linked to Increased Activity in Rheumatic Diseases
• FDA Accepts BLA for Samsung Bioepis' Humira Biosimilar
• FDA Panel Unanimously Backs Rituxan Biosimilar for Lymphoma
• Obesity and Arthritis: Science and Realpolitik Leonard H. Calabrese, DO
• Post-surgical Opioid Prescriptions not a 'One-Size-Fits All' Approach
• Shortage of Pediatric Rheumatologists Hinders Care for Children, Adolescents
• Canadian Rheumatology Association Recommends CV Risk Assessment Upon Lupus Diagnosis
• EULAR Recommends Against Treating Hand OA With Conventional, Biologic DMARDs
• Proposal Offers 'Refined' Definition of Autoinflammatory Disease
• Rheumatologists Vary Widely on Defining Traits of Hard-to-treat RA
• Bone Erosions, Enthesophytes Enhanced in PsA
• End-stage Renal Disease Mortality Fell From 1995 to 2014 in Lupus Nephritis
• High Risk for Gout Persists After First Year of Obstructive Sleep Apnea
• Low RA Disease Activity, Remission Retained After Baricitinib Reduction
• More Than 5 Years of Statin Use Lowers Risk for OA Knee Pain
• Ontario Psoriasis, PsA Prevalence on the Rise
• Open-label Studies Preferable to Double-blind Parallel Trials for Childhood SLE Treatments
• Patients With SSc-related Raynaud's Syndrome Identify With Patterns Linked to Microangiopathy
• Acthar Gel Offers Potential Alternative for Unresponsive, Persistent RA
• Baricitinib 4 mg Linked to SLE Improvements
• Genetic Risk Score Effective, Less Costly Alternative to MRI in AS Diagnosis
• High-dose Flu Vaccine Improves Immune Response in RA
• PET/CT Combination Accurately Diagnoses Giant Cell Arteritis
• Canadian Clinics Marketing Unapproved Stem Cell Treatments
• CANTOS: Quarterly Canakinumab Reduced Risk of Gout Attack by Half
• Dual-eligible Medicare, Medicaid Beneficiaries Subject to Persistently High Costs
• Outpatient Engagement Lowers Suicide Risk in Fibromyalgia
• Positive Psychological Interventions Ineffective for OA Pain
• Tocilizumab's CV Risk Comparable to That of Etanercept, Other RA Biologics